Triamcinolone acetonide injections for the treatment of recalcitrant post-radical prostatectomy vesicourethral anastomotic stenosis: A retrospective look at efficacy and safety

Abstract

Introduction: We aimed to evaluate the success of bladder neck injections of triamcinolone at the time of transurethral bladder neck incision (BNI) for prevention of recurrent vesicourethral anastomotic stenosis (VUAS) following prostate cancer treatment.
 Methods: This is a retrospective cohort study examining patients with recurrent VUAS post-RP ± radiation treated with triamcinolone injections at the time of BNI. VUAS was diagnosed by symptoms followed by cystoscopy or urethrography. The outpatient procedures were done under general anesthesia. Cold knife incisions were made at the three, nine, and 12 o’clock BN positions, followed by triamcinolone injections (4 mg/mL) into the three and nine o’clock incision sites. Treatment outcomes were determined with cystoscopy.
 Results: Eighteen men underwent 25 procedures over a four-year period. Median age at diagnosis of VUAS was 65 (interquartile range [IQR] 61–68); median time to VUAS from RP was eight months (IQR 5–12). Fourteen patients (78%) had radiation treatment. The cohort had 128 unsuccessful VUAS treatments, with a median of five failed treatments per patient (IQR 3–10). Failed treatments included BN dilation, BNI, BN injection of mitomycin C, and urethral stent placement. Success rate after a mean of 16.3 months (standard deviation [SD] 8.1) from the time of triamcinolone injection was 83% (15/18). Six patients went on to have successful incontinence surgery. Five patients (28%) had treatment complications (bleeding, urinary tract infection, pain, and urinary extravasation). The three non-responders are stable and awaiting re-treatment with triamcinolone injection.
 Conclusions: Triamcinolone bladder neck injections for post-RP VUAS are a useful and safe treatment for recurrent stenosis.

Post‐prostatectomy anastomotic stenosis: systematic review and meta‐analysis of endoscopic treatment

“…The risk of bias assessment was unfavourable for a large majority of studies regarding the measurement of the condition (utilisation of valid method, measurement in a standard, reliable way; Fig. 3 [1,19,27–64]).…”

The efficacy and safety of mitomycin C intra urethral injection to prevent recurrent urethral stricture: A systematic review and meta-analysis

“…The PRISMA guideline was implemented in the study selection. Several studies were excluded due to several reasons, including inappropriate study design [ [11] , [12] , [13] , [14] ], inappropriate comparison [ [15] , [16] , [17] , [18] ] [ [15] , [16] , [17] , [18] ] [ [15] , [16] , [17] , [18] ], observational studies [ 16 , [19] , [20] , [21] ] and an abstract-only articles [ 22 ].…”

Refractory Bladder Neck Contracture (BNC) After Radical Prostatectomy: Prevalence, Impact and Management Challenges

“…Its first-time success rate ranges between 70% and 85%. [55][56][57][58][59] MMC gives a first-time success rate between 45% and 79%. [48][49][50][51][52][53][54] An anti-fibrinogenic DNA alkylating agent, it prevents DNA replication and therefore cell growth.…”